These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. TUBB4B is a novel therapeutic target in non-alcoholic fatty liver disease-associated hepatocellular carcinoma. Yang Z; Gao S; Wong CC; Liu W; Chen H; Shang H; Wu ZY; Xu L; Zhang X; Wong N; Kuang M; Yu J J Pathol; 2023 May; 260(1):71-83. PubMed ID: 36787097 [TBL] [Abstract][Full Text] [Related]
23. Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns. Zeng F; Zhang Y; Han X; Zeng M; Gao Y; Weng J Front Immunol; 2020; 11():609900. PubMed ID: 33574818 [TBL] [Abstract][Full Text] [Related]
24. A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet. Motiño O; Li S; Lambertucci F; Anagnostopoulos G; Montégut L; Nogueira-Recalde U; Chen H; Maiuri MC; Kroemer G; Martins I Methods Mol Biol; 2024; 2769():67-75. PubMed ID: 38315389 [TBL] [Abstract][Full Text] [Related]
25. Translational approaches: from fatty liver to non-alcoholic steatohepatitis. Rosso N; Chavez-Tapia NC; Tiribelli C; Bellentani S World J Gastroenterol; 2014 Jul; 20(27):9038-49. PubMed ID: 25083077 [TBL] [Abstract][Full Text] [Related]
26. [Research advances in the pathogenesis of non-alcoholic fatty liver disease-associated liver cancer]. Huang W; Zhang XX Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):157-160. PubMed ID: 28297806 [TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. Wong CR; Nguyen MH; Lim JK World J Gastroenterol; 2016 Oct; 22(37):8294-8303. PubMed ID: 27729736 [TBL] [Abstract][Full Text] [Related]
28. Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment. Argyrou C; Moris D; Vernadakis S J BUON; 2017; 22(1):6-20. PubMed ID: 28365930 [TBL] [Abstract][Full Text] [Related]
29. Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease. Moreno-Fernandez ME; Giles DA; Stankiewicz TE; Sheridan R; Karns R; Cappelletti M; Lampe K; Mukherjee R; Sina C; Sallese A; Bridges JP; Hogan SP; Aronow BJ; Hoebe K; Divanovic S JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563328 [TBL] [Abstract][Full Text] [Related]
30. Fatty Liver Disease and Hepatocellular Carcinoma: The Pathologist's View. Tiniakos DG; Maurício J; Reeves HL Adv Exp Med Biol; 2018; 1032():55-69. PubMed ID: 30362090 [TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms and oxidative stress in non-alcoholic steatohepatitis (NASH): A mini review. Oliveira CP; Stefano JT Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S35-40. PubMed ID: 26160475 [TBL] [Abstract][Full Text] [Related]
32. Autophagy, NAFLD and NAFLD-Related HCC. Wu WKK; Zhang L; Chan MTV Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211 [TBL] [Abstract][Full Text] [Related]
33. Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC. Liu K; McCaughan GW Adv Exp Med Biol; 2018; 1061():3-18. PubMed ID: 29956203 [TBL] [Abstract][Full Text] [Related]
34. The Natural Course of Non-Alcoholic Fatty Liver Disease. Calzadilla Bertot L; Adams LA Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213358 [TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNAs as modulators and therapeutic targets in non-alcoholic fatty liver disease (NAFLD). Tao Q; Xie J; Wu Y; Jin Y Gastroenterol Hepatol; 2024 May; 47(5):506-516. PubMed ID: 37806343 [TBL] [Abstract][Full Text] [Related]
36. Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease. Fisher CP; Kierzek AM; Plant NJ; Moore JB World J Gastroenterol; 2014 Nov; 20(41):15070-8. PubMed ID: 25386055 [TBL] [Abstract][Full Text] [Related]
37. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Su Q; Kumar V; Sud N; Mahato RI Adv Drug Deliv Rev; 2018 Apr; 129():54-63. PubMed ID: 29391222 [TBL] [Abstract][Full Text] [Related]
38. Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease. Lakhani HV; Sharma D; Dodrill MW; Nawab A; Sharma N; Cottrill CL; Shapiro JI; Sodhi K Int J Med Sci; 2018; 15(14):1591-1599. PubMed ID: 30588181 [TBL] [Abstract][Full Text] [Related]